No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Instruments & Supplies
BATM Advanced Communications Ltd., alongside its affiliated companies, specializes in the innovation, production, and commercialization of cutting-edge real-time technologies throughout Israel, the United States, and Europe. The enterprise conducts its operations through two distinct divisions: Networking and Cybersecurity, and Bio-Medical. The Networking and Cybersecurity division is responsible for the research, development, manufacturing, and market introduction of various data communication products. These offerings encompass technologies such as network function virtualization, edge computing, carrier ethernet, MPLS access solutions, advanced cyber network monitoring, and robust network encryption. Additionally, this segment delivers a range of software services, including user training, technical support, laboratory assistance, and ongoing maintenance, as well as undertaking construction contracts. Conversely, the Bio-Medical division focuses on delivering molecular biology diagnostic tools and provides comprehensive solutions for managing and neutralizing hazardous pathogenic and medical waste generated in environments like laboratories, hospitals, pharmaceutical production facilities, and agricultural settings. This segment also performs diverse testing services and serves as a distributor for a wide array of diagnostic apparatus and medical consumables from various brands. Established in 1992, BATM Advanced Communications Ltd. maintains its principal corporate office in Hod Hasharon, Israel.
coming-soon.batm.comNo one on the platform currently holds BVC.TA.
No tracked institution reports a position in BVC.TA as of their last filing.
No one on the platform has traded BVC.TA yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | — | — | — | |||
| Rev. Growth % | 7.3% | -7.3% | ||||
| Profit Margin % | -12.3% | -4.2% | -1.3% | |||
| Free Cash Flow Margin % | -7.2% | -2.8% | -1.2% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $91M | -26.5% | $0.00 | $0.00–$0.00 | — | 1 |
| 2027 | $100M | +10.0% | $0.01 | $0.01–$0.01 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| BVC.TABATM Advanced Communications Ltd. | $47.30 | +0.85% | $161M | — |
| BONS.TABonus BioGroup Ltd. | $17.70 | +2.31% | $207M | — |
| DNA.TADna Group (T.R.) Ltd | $110.90 | +0.00% | $137M | — |
| EPIT.TAEpitomee Medical Ltd | $401.50 | +9.34% | $121M | — |
| GOHO.TAGolden House Ltd | $1092.00 | +1.49% | $169M | — |
| INCR.TAInterCure Ltd. | $1620.00 | -0.18% | $192M |
Source: Financial Modeling Prep · peers by sector/industry
| — |
| NISA.TANissan Medical Industries Ltd | $940.10 | +0.01% | $85M | — |